These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 19544759

  • 21. Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study.
    Spierings EL, McAllister PJ, Bilchik TR.
    Cranio; 2015 Apr; 33(2):115-21. PubMed ID: 25323219
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo.
    Menza M, Dobkin RD, Marin H, Gara M, Bienfait K, Dicke A, Comella CL, Cantor C, Hyer L.
    Mov Disord; 2010 Aug 15; 25(11):1708-14. PubMed ID: 20589875
    [Abstract] [Full Text] [Related]

  • 25. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.
    Curr Med Res Opin; 2006 Sep 15; 22(9):1633-42. PubMed ID: 16968566
    [Abstract] [Full Text] [Related]

  • 26. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
    Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T.
    Sleep; 2003 Nov 01; 26(7):793-9. PubMed ID: 14655910
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN, Joffe H, Rubens R, Caron J, Roth T, Cohen L.
    Obstet Gynecol; 2006 Dec 01; 108(6):1402-10. PubMed ID: 17138773
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
    Jhaveri M, Seal B, Pollack M, Wertz D.
    Curr Med Res Opin; 2007 Jun 01; 23(6):1431-43. PubMed ID: 17559740
    [Abstract] [Full Text] [Related]

  • 32. Eszopiclone for the treatment of primary insomnia: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.
    Liang L, Huang Y, Xu R, Wei Y, Xiao L, Wang G.
    Sleep Med; 2019 Oct 01; 62():6-13. PubMed ID: 31518944
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia.
    Zammit GK, McNabb LJ, Caron J, Amato DA, Roth T.
    Curr Med Res Opin; 2004 Dec 01; 20(12):1979-91. PubMed ID: 15701215
    [Abstract] [Full Text] [Related]

  • 36. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.
    Sleep Med; 2005 Nov 01; 6(6):487-95. PubMed ID: 16230048
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration.
    Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN.
    BMJ; 2012 Dec 17; 345():e8343. PubMed ID: 23248080
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.